← All Sponsors
SPONSOR

Napo Pharmaceuticals, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Microvillus Inclusion DiseaseCongenital DisordersRare Diseases
NCT06721871 Phase 2
Recruiting

Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

Microvillus Inclusion Disease
United States, Italy, United Arab Emirates View Trial →